MenuМеню
  • Home
  • About Us
  • Medicines
  • Partnering
  • Professionals
  • Responsibility
  • News & Media
  • Careers
  • Investors
  • English
  • Bulgarian

News and Media

  • Financial News
  • News
  • Opinion Pieces
  • Press Releases
  • July 7, 2021

    Banker: In early July 2021 Tchaikapharma confirms its position as the most expensive Bulgarian company

    The first half of this year did not bring much of a stir in stock trading as a consequence of both the development of the pandemic and the slow recovery of the economy.   However, at the end of June this year, the Bulgarian Stock Exchange had a public company with a market capitalization of […]

  • May 21, 2021

    Tchaikapharma’s shares rose 292.757% in 6 years on the BSE

    Tchaikapharma Highquality Medicines, a flagship company on the Bulgarian pharma market, started trading shares on the Bulgarian Stock Exchange (BSE) on 21 May 2015. On today’s date exactly 6 years ago, the initial offering price per share was BGN 3.59, and on 21 May 2021 – BGN 14.10. This represents a growth of 292.757% over […]

  • February 23, 2021

    Bulgaria’s Tchaikapharma gets shareholders nod for 14 mln euro loan for new plant

    SOFIA (Bulgaria), February 23 (SeeNews) – Bulgarian drug maker Tchaikapharma High Quality Medicines [BUL:7TH] said that its shareholders have approved its plan to borrow up to 14 million euro ($17.2 million) in order to finance the construction of a new production plant just outside Sofia.   The proposal was supported by all shareholders present at […]

  • February 3, 2021

    A company of over one billion leva market capitalization on the BSE

    At the beginning of February, one share of the company costs BGN 13.80, which means that the market capitalization of the pharmaceutical equals 1.13 billion leva.   Read the full article here in Bulgarian.

  • December 22, 2020

    Engr. Biser Georgiev, Executive Director: With a market cap of over BGN 1 billion Tchaikapharma remains the most expensive public company

    We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficult time, we could assure that the Bulgarian population had access to reliable and affordable medical prevention and early COVID-19 treatment with hydroxychloroquine. At the […]

  1. Previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. ...
  12. 36
  13. Next
Copyright © 2010-2025 Tchaikapharma Inc.
  • Contact Us